Objective-To evaluate the effect of cardioversion on peak oxygen consumption (peak Vo2) in patients with long-standing atrial fibrillation, to assess the importance of underlying heart disease with respect to the response to exercise, and to relate functional capacity to long-term arrhythmia outcome.
(n = 37) increased from 21-4 (5.8) to 2307 (6.4) ml/minlkg (+11%, P < 0*05), whereas in patients with a recurrence of atrial fibrillation 1 month after cardioversion (n = 26) peak Vo2 was unchanged. In patients who were in sinus rhythm both those with and without underlying heart disease improved, and improvement was not related to functional capacity or left ventricular finction before cardioversion. Baseline peak Vo2 was not a predictive factor for longterm arrhythmia outcome. Conclusion-Restoration of sinus rhythm improved peak Vo, in patients with atrial fibrillation, irrespective of the presence of underlying heart disease. Peak Vo, was not a predictive factor for long-term arrhythmia outcome after cardioversion of atrial fibrillation. These findings suggest that cardioversion is the best method of improving functional capacity in patients with atrial fibrillation, whether or not they have underlying heart disease and whatever their functional state. (Br HeartJ_ 1994; 72:161-166) In atrial fibrillation, loss of atrial contraction and an excessive response of heart rate to exercise may be detrimental to cardiac output because they impair ventricular diastolic filling.lA As a consequence, functional capacity in patients with atrial fibrillation may be reduced. 5 Though cardioversion of atrial fibrillation is often performed its effect on functional status has not been extensively studied. Measurement of peak oxygen consumption (peak Vo) by gas exchange analysis is an accurate and objective non-invasive method of determining functional capacity.-l1 So far, there have been only three small studies of the effect of cardioversion on peak Vo2 in atrial fibrillation. [11] [12] [13] The aim of the present prospective study was to analyse the effect of cardioversion on peak Vo, a month after cardioversion in a large cohort of patients with long-standing, chronic atrial fibrillation; patients who had a relapse of atrial fibrillation served as a control group. We also studied the importance of underlying heart disease with respect to functional capacity in atrial fibrillation and assessed the predictive value of functional capacity for long arrhythmia outcome by measuring baseline peak Vo2.
Patients and methods

PATIENTS
All consecutive patients with chronic atrial fibrillation selected between June 1989 and February 1992 to undergo electrical cardioversion were eligible for the study. Exclusion criteria were (a) paroxysmal atrial fibrillation; (b) myocardial infarction within the past 6 months; (c) thyroid dysfunction; (d) use off adrenergic blocking agents; and (e) angina, chronic obstructive pulmonary disease, claudication, or any other abnormality intefering with the performance of a treadmill exercise test. The study was approved by the Institutional Review Board and informed consent for participation in the study was obtained from all patients.
STUDY DESIGN
Patients underwent exercise testing a day before and 4 weeks after cardioversion. In all patients anticoagulant therapy was started to maintain prothrombin time within a target range of 1 5-2-0 x control at least 4 weeks before cardioversion. Atrioventricular nodal blocking drugs (digitalis, verapamil, or both) were titrated to attain a resting heart rate A 100 beats per minute at least 2 months before cardioversion. Twenty patients were taking antiarrhythmic drugs (VaughanWilliams class I, 15 patients; class III, 5 patients). Drug treatment was unchanged throughout the study. Before cardioversion a standard cross sectional echocardiogram was performed in all patients to assess left atrial size and left ventricular function as measured by left ventricular fractional shortening. Cardioversion was carried out according to a previously described protocol.'4 Patients visited the outpatient department 1, 3, and 6 months after cardioversion and every 6 months thereafter. At each visit a 12 lead electrocardiogram and 24 hour Holter monitoring (Marquette Laser Holter System, Milwaukee, Wisconsin, USA) were performed to determine the rhythm. Exercise data for patients who were in sinus rhythm 1 month after cardioversion were compared with those of patients who could not be cardioverted or had a relapse of atrial fibrillation 1 month after cardioversion.
EXERCISE TESTING WITH RESPIRATORY GAS ANALYSIS
Exercise testing with measurement of respiratory gas exchange was performed while patients exercised on a treadmill according to a modified Naughton protocol.5 16 Oxygen consumption, carbon dioxide production, and respiratory exchange ratios were measured continuously during exercise by an automated system for measuring gas exchange (Sensormedics system 2900, SensorMedics Corp, Anaheim, California, USA). Values were recorded every 20 s through an on-line (18) 44 (7) 52 (7) 37 (8) 30 (7) 93 (19) 133 (20) 84 (10) 174 (30) 171 (24) 85 (12) 19-0 (4-3) 213 (6-1) 77 (19) computer assembly (IBM computer systems, IBM Corp, Austin, Texas, USA). Before each exercise test, the flow meter was calibrated with 31 syringe and the gas analysers were calibrated with nitrogen and a standard oxygen/carbon dioxide mixture. Blood pressure was measured with a mercury sphygmomanometer. The electrocardiogram was monitored continuously with a computer-assisted system (Marquette Electronics, Milwaukee, Wisconsin, USA). Twelve lead electrocardiogram recordings were obtained at rest, at the end of each 2 minute stage, and at peak exercise. Before entering the study, patients underwent at least one test to familiarise themselves with this gas exchange analysis. Patients were encouraged to exercise until symptoms forced them to stop. All patients stopped the test because of dyspnoea or fatigue; and in all patients the gas exchange anaerobic threshold (the point at which carbon dioxide production increased disproportionately in relation to oxygen consumption) and a respiratory exchange ratio > 1 0 were reached. Peak Vo2 was defined as oxygen consumption (ml/min/kg) at peak exercise calculated as the mean of the values measured during the last minute of exercise. Heart rate during atrial fibrillation was determined by measuring the average heart rate for a 15 s period. The predicted peak Vo2 was calculated by the following formulas'7 18:
Men: peak Vo2 (ml/min/kg) = 60 -(age x 0-55) Women: peak Vo2 (ml/min/kg) = 48 -(age x 0-37).
Maximal heart rate was compared with the predicted maximal heart rate. '9 PEAK OXYGEN CONSUMPTION AND LONG-TERM ARRHYTHMIA OUTCOME
To determine the effect of precardioversion functional capacity on long-term maintenance of sinus rhythm we categorised patients in two groups according to the peak Vo2 they attained before cardioversion. We used the age and sex predicted peak Vo2 of 70% as the cutoff point. 20 We also studied other factors known to influence long-term arrhythmia outcome: arrhythmia duration,2'-23 left atrial size,2' 2324 left ventricular function,25 presence and type of underlying heart disease,232627 and New York Heart Association class.28 LONE ATRIAL FIBRILLATION VERSUS UNDERLYING HEART DISEASE To study the influence of underlying heart disease on response to exercise we categorised patients as those with lone atrial fibrillation and those with underlying heart disease.
Exercise data before and after cardioversion were compared in both groups.
DEFINITION OF TERMS
Chronic atrial fibrillation was defined as atrial fibrillation lasting > 6 months, without intercurrent sinus rhythm. Underlying heart disease was determined from the patient's history and physical examination, as well as from the chest x ray, echocardiography, and coronary angiography when available. Total Functional capacity before and after cardioversion of atrialfibrillation: a controled study Table 3 shows exercise data before and after cardioversion in patients who were still in sinus rhythm and those who were in atrial fibrillation 1 month after cardioversion. Exercise testing before cardioversion did not show statistically significant differences between both groups. In patients who had maintained sinus rhythm 1 month after cardioversion, mean peak Vo, increased by 11%, from 21-4 (5 8) to 23-7 (6 4) mI/min/kg (P < 0 05). Figure 1 shows peak Vo2 before and after cardioversion in each patient. Improvement of peak Vo2 after cardioversion was not correlated with precardioversion peak Vo, left ventricular fractional shortening, or changes in (maximal) heart rate after cardioversion. In contrast, peak Vo, and other exercise variables did not change in patients who were in atrial fibrillation 1 month after cardioversion. Table 4 Clinical and exercise data (mean (ISD)) ofpatients with underling heart disease compared with those with lone atrialfibrillation before cardioversion mia outcome. Thus peak Vo2 was not a predictive factor for the maintenance of sinus rhythm. Also none of the established clinical variables including echocardiographic left atrial size and New York Heart Association class were of predictive value in terms of longterm arrhythmia outcome in the present study.
LONE ATRIAL FIBRILLATION VERSUS UNDERLYING HEART DISEASE
Before cardioversion
Before cardioversion mean peak Vo2 in patients with lone atrial fibrillation was 24-7 (6.0) ml/min/kg and 87 (16%) when expressed as a percentage of the age and sex predicted maximum (table 4). Mean peak Vo2 in patients with underlying heart disease was significantly lower than in patients with lone atrial fibrillation: 19-5 (4.4) ml/min/kg (P < 0.01) and 72 (18%) (P < 0-01) of that predicted. Maximal heart rate was significantly higher in patients with lone atrial fibrillation than in patients with underlying heart disease. In patients with lone atrial fibrillation there was a significant correlation between maximal heart rate and peak Vo2 (r = 0-68, P = 0 001, figure 2A ). There was no correlation in patients with underlying heart disease (figure 2B).
One month after cardioversion
In patients in sinus rhythm after 1 month, peak Vo2 improved both in patients with (n = 28) and without (n = 9) underlying heart disease, from 19-8 (4-8) to 22.2 (5-2) ml/min/kg (P < 0-05) and from 26-1 (6 6) to 28-3 (7.5) ml/min/kg (P < 0 05) respectively (fig 3) . The difference in improvement between both groups of patients (12% and 8% respectively) was not statistically significant. In patients without underlying heart disease peak Vo2 after cardioversion was similar to that predicted for controls, whereas in patients with underlying heart disease it was 78% of that in controls. Resting heart rate and heart rate at peak exercise decreased by 20% in both groups. Whereas maximal heart rate after cardioversion in patients without underlying heart disease was similar to percentage of the age and sex predicted maximum, (C) resting heart rate, and (D) maximal heart rate in atrialfibrillation (AF) patients (n = 28) and without underlying heart disease (n = 9) before cardioversion and after 1 month ofsinus (SR) rhythm. P < 005 versus values before cardioversion. Peak Vo,, peak oxygen consumption.
that of controls, in patients with underlying heart disease it was only 80% of that in controls.
PREDICTORS OF PEAK OXYGEN CONSUMPTION DURING ATRIAL FIBRILLATION
Stepwise regression analysis, with pre-cardioversion peak Vo, as the dependent variable, indicated that sex, age, and the presence of underlying heart disease were significant multivariate predictors of peak Vo, during atrial fibrillation.
Discussion
Three previous studies used gas exchange analysis to study the effect of cardioversion on exercise capacity in patients with atrial fibrillation.'1-1'3 As in our study, they showed an increase in peak Vo The present study did not show that peak Vo2 was a predictive factor for long-term arrhythmia outcome after cardioversion. In contrast, one previous study reported that a better functional state, expressed as New York Heart Association class, was associated with a longer arrhythmia-free episode after cardioversion. 28 One possible explanation for the present finding is that the high arrhythmia recurrence rate, presumably caused by the long total duration of arrhythmia, precluded detection of peak Vo2 as a predictive factor for arrhythmia outcome. This is supported by the observation that none of the established risk factors for predicting arrhythmia relapses was statistically significant in our study. An alternative explanation may be that patients with a relatively high peak Vo2-that is, patients with lone atrial fibrillation-have an unfavourable long-term arrhythmia outcome"3 (probably because of primary electrophysiological abnormalities of the atria), whereas patients with a relatively low peak VO2-that is, patient with coexistent heart disease-have a high recurrence rate caused by the underlying heart disease. This would also explain the inability to discriminate between a favourable and unfavourable long-term arrhythmia outcome by means of peak Vo,. Nevertheless, from a clinical point of view, our findings suggest that the opportunity to restore sinus rhythm should not be withheld from patients with atrial fibrillation and a low functional capacity merely because of an impaired functional status.
PREDICTORS OF PEAK OXYGEN CONSUMPTION DURING ATRIAL FIBRILLATION
In the present study the only clinical factors predicting peak Vo, during atrial fibrillation were age, sex, and presence of underlying heart disease. These findings contrast with the results of an earlier study, which stressed the importance of maximal heart rate in predicting maximal oxygen consumption.5 In our study a significant relation between maximal heart rate and peak Vo, was found only in patients with lone atrial fabrillation ( figure  2A ). The absence of a similar relation in patients with underlying heart disease was mainly the result of an excessive heart rate combined with a low peak Vo, in many of these patients (upper left quadrant of fig 2B) . Obviously, in patients with underlying heart disease and a low peak Vo, the "normal" relation between functional capacity and heart rate response is lost. Presumably, an enhanced adrenergic drive32 and adaptive mechanisms in the peripheral circulation3334 may be responsible for this low peak Vo2 despite a high heart rate during exercise in these patients.
STUDY LIMITATIONS
Although we compared results of patients maintaining sinus rhythm after cardioversion with a control group of patients remaining in atrial fibrillation, patients were not randomised to cardioversion or pharmacological rate control only. This may have introduced a bias leading to selection of patients in the control group who did not improve their exercise capacity for reasons other than arrhythmia outcome. However, at baseline, patient groups were similar, and established clinical indices for predicting relapse were similar in the two groups.
CONCLUSIONS AND CLINICAL IMPLICATIONS
Restoration of sinus rhythm improved peak Vo2 in patients with chronic atrial fibrillation.
This holds both for patients with underlying heart disease and without. Also, functional state was not a predictive factor for long-term maintenance of sinus rhythm after cardioversion. Our findings suggest that cardioversion is the best method of improving functional capacity in patients with atrial fibrillation, irrespective of the presence of underlying heart disease and the functional state.
